Literature DB >> 1817955

Anticonvulsant effects of phenobarbital and primidone during ontogenesis in rats.

H Kubova1, P Mares.   

Abstract

The influence of phenobarbital (PHB, 10, 20, 40 or 80 mg/kg i.p.) and primidone (PRI, 40 or 80 mg/kg i.p.) on metrazol-induced motor seizures was studied in rats 7, 12, 15, 18, 25 and 90 days old. PHB blocked both types of seizures induced by metrazol-minimal (mMS) as well as generalized tonic-clonic (MMS)--in all age groups where they appeared under control conditions. The effect against major seizures was always better expressed than against mMS. Pretreatment with PHB led to the appearance of mMS in 7- and 12-day-old rat pups, where control animals did not exhibit this type of seizure. Combined administration of the 2 high doses of PHB and metrazol resulted in the appearance of behavioral automatisms in young rats. PRI abolished MMS in adult rats only, no changes were seen in 25-day-old animals and specific suppression of the tonic phase of MMS was observed in younger rats. mMS were influenced only in 7- and 12-day-old rats, where an increase in their incidence was recorded. Pretreatment with PRI never induced automatisms. The different actions of PHB and PRI speak in favor of an anticonvulsant action of PRI itself.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1817955     DOI: 10.1016/0920-1211(91)90007-3

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  14 in total

1.  Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal rats.

Authors:  Patrick A Forcelli; Colin Soper; Anne Duckles; Karen Gale; Alexei Kondratyev
Journal:  Epilepsy Res       Date:  2013-10-05       Impact factor: 3.045

2.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

3.  Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.

Authors:  Sari Frankel; Natalia Medvedeva; Samuel Gutherz; Catherine Kulick; Alexei Kondratyev; Patrick A Forcelli
Journal:  Epilepsy Behav       Date:  2016-02-24       Impact factor: 2.937

4.  Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.

Authors:  Catherine Kulick; Samuel Gutherz; Alexei Kondratyev; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-06-23       Impact factor: 4.432

5.  Brief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats.

Authors:  Samuel B Gutherz; Catherine V Kulick; Colin Soper; Alexei Kondratyev; Karen Gale; Patrick A Forcelli
Journal:  Epilepsy Behav       Date:  2014-08-12       Impact factor: 2.937

6.  Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats.

Authors:  Patrick A Forcelli; Ryan Kozlowski; Charles Snyder; Alexei Kondratyev; Karen Gale
Journal:  J Pharmacol Exp Ther       Date:  2011-11-30       Impact factor: 4.030

7.  Preclinical safety and efficacy of cannabidivarin for early life seizures.

Authors:  Megan N Huizenga; Alberto Sepulveda-Rodriguez; Patrick A Forcelli
Journal:  Neuropharmacology       Date:  2019-01-10       Impact factor: 5.250

8.  Profile of retigabine-induced neuronal apoptosis in the developing rat brain.

Authors:  Lindsay Brown; Samuel Gutherz; Catherine Kulick; Colin Soper; Alexei Kondratyev; Patrick A Forcelli
Journal:  Epilepsia       Date:  2016-02-10       Impact factor: 5.864

9.  Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats.

Authors:  Megan N Huizenga; Patrick A Forcelli
Journal:  Neurotox Res       Date:  2018-08-24       Impact factor: 3.911

10.  Profile of anticonvulsant action of levetiracetam, tiagabine and phenobarbital against seizures evoked by DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in neonatal rats.

Authors:  Catherine V Kulick; Samuel B Gutherz; Veronica C Beck; Natalia Medvedeva; Colin Soper; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-09-22       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.